Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls

Neurosurgery

Volumn 57, Issue 5, 2005, Pages 997-1006

  Kilic, Türker ^a   Sohrabifar, Mehran ^a   Kurtkaya, Özlem ^a   Yildirim, Özlem ^a   Elmaci, Ilhan ^a   Günel, Murat ^b   Necmettin Pamir, M Necmettin ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aneurysms; Angiogenesis; Collagen; Fibroblast growth factor; Fibronectin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; STRUCTURAL PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ANEURYSM CLIP; ANEURYSM RUPTURE; ANGIOGENESIS; ARTICLE; BRAIN CIRCULUS ARTERIOSUS; CADAVER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

ACTINS; ADULT; ANEURYSM, RUPTURED; CASE-CONTROL STUDIES; COLLAGEN TYPE III; COLLAGEN TYPE IV; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL ANEURYSM; LAMININ; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 27644448931     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000180812.77621.6C     Document Type: Article

References (64)

1. Aebersold DM, Froehlich SC, Jonczy M, Beer KT, Laissue J, Greiner RH, Djonov V: Expression of transforming growth factor-α, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy. Radiother Oncol 63:275-283, 2002.
2. Anderson DW, Edwards TK, Ricketts MH, Kuivaniemi H, Tromp G, Stolle CA, Deak SB, Boyd CD: Multiple defects in type III collagen synthesis are associated with the pathogenesis of abdominal aortic aneurysms. Ann N Y Acad Sci 800:216-228, 1996.
3. Andrews RJ: Collagen in cerebral aneurysms, mitral valve prolapse, and von Willebrand syndrome. Stroke 15:917-918, 1984.
4. Auguste P, Javerzat S, Bikfalvi A: Regulation of vascular development by fibroblast growth factors. Cell Tissue Res 314:157-166, 2003.
5. Barrow DL, Reisner A: Natural history of intracranial aneurysms and vascular malformations. Clin Neurosurg 40:3-39, 1993.
6. Botta M, Manetti F, Corelli F: Fibroblast growth factors and their inhibitors. Curr Pharm Des 6:1897-1924, 2000.
7. Brega KE, Seltzer WK, Munro LG, Breeze RE: Genotypic variations of type III collagen in patients with cerebral aneurysms. Surg Neurol 46:253-256; discussion 256-257, 1996.
8. Brooks PC: Role of integrins in angiogenesis. Eur J Cancer 32A:2423-2429, 1996.
9. Bruno G, Todor R, Lewis I, Chyatte D: Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg 89:431-440, 1998.
10. Chyatte D, Lewis I: Gelatinase activity and the occurrence of cerebral aneurysms. Stroke 28:799-804, 1997.
11. Coutard M, Osborne-Pellegrin M: Genetic susceptibility to experimental cerebral aneurysm formation in the rat. Stroke 28:1035-1042, 1997.
12. Cupo LN, Pyeritz RE, Olson JL, McPhee SJ, Hutchins GM, McKusick VA: Ehlers-Danlos syndrome with abnormal collagen fibrils, sinus of Valsalva aneurysms, myocardial infarction, panacinar emphysema and cerebral heterotopias. Am J Med 71:1051-1058, 1981.
13. de la Monte SM, Moore GW, Monk MA, Hutchins GM: Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med 78:957-964, 1985.
14. de Paiva Magalhaes E, Fernandes SR, Zanardi VA, Furtado Medeiros CA, Midori RY, Sachetto Z, Samara AM: Ehlers-Danlos syndrome type IV and multiple aortic aneurysms: A case report. Angiology 52:223-228, 2001.
15. Deniz ML, Kilic T, Almaata I, Kurtkaya O, Sav A, Pamir MN: Expression of growth factors and structural proteins in chordomas: Basic fibroblast growth factor, transforming growth factor-α, and fibronectin are correlated with recurrence. Neurosurgery 51:753-760, 2002.
16. Ferguson GG: Physical factors in the initiation, growth, and rupture of human intracranial saccular aneurysms. J Neurosurg 37:666-677, 1972.
17. Fogelholm R: Subarachnoid hemorrhage in middle-Finland: Incidence, early prognosis and indications for neurosurgical treatment. Stroke 12:296-301, 1981.
18. Garbisa S, Negro A: Macromolecular organization and functional architecture of basement membranes. Appl Pathol 2:217-222, 1984.
19. Halloran BG, Baxter BT: Pathogenesis of aneurysms. Semin Vasc Surg 8:85-92, 1995.
20. Heiskanen O: Risks of surgery for unruptured intracranial aneurysms. J Neurosurg 65:451-453, 1986.
21. Heiskanen O, Poranen A: Surgery of incidental intracranial aneurysms. Surg Neurol 28:432-436, 1987.
22. Holmes B, Harbaugh RE: Traumatic intracranial aneurysms: A contemporary review. J Trauma 35:855-860, 1993.
23. Huang TY, Lin CL, Chang CZ, Howng SL: Familial intracranial aneurysms. Kaohsiung J Med Sci 14:242-246, 1998.
24. Jain KK: Surgical treatment of unruptured intracranial aneurysms. Acta Neurochir (Wien) 66:187-194, 1982.
25. Jones DB: Aetiology of cerebral aneurysms. Lancet 1:1265, 1981.
26. Juvela S: Natural history of unruptured intracranial aneurysms: Risks for aneurysm formation, growth, and rupture. Acta Neurochir Suppl 82:27-30, 2002.
27. Kassam A, Horowitz M, Chang YF, Peters D: Altered arterial homeostasis and cerebral aneurysms: A review of the literature and justification for a search of molecular biomarkers. Neurosurgery 54:1199-1212, 2004.
28. Kassam AB, Horowitz M, Chang YF, Peters D: Altered arterial homeostasis and cerebral aneurysms: A molecular epidemiology study. Neurosurgery 54:1450-1460, 2004.
29. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R: Structural fragility and inflammatory response of ruptured cerebral aneurysms: A comparative study between ruptured and unruptured cerebral aneurysms. Stroke 30:1396-1401, 1999.
30. Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PMcL: Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46:1179-1191, 2000.
31. Krum JM, More NS, Rosenstein JM: Brain angiogenesis: Variations in vascular basement membrane glycoprotein immunoreactivity. Exp Neurol 111:152-165, 1991.
32. Kuivaniemi H, Prockop DJ, Wu Y, Madhatheri SL, Kleinert C, Earley JJ, Jokinen A, Stolle C, Majamaa K, Myllyla VV, Noerrgaard O, Schievink WI, Mokri B, Fukawa O, Ter Berg JW, de Paepe A, Lozano AM, Leblanc R, Ryynaenen M, Baxter BT, Shikata H, Ferrell RE, Tromp G: Exclusion of mutations in the gene for type III collagen (COL3A1) as a common cause of intracranial aneurysms or cervical artery dissections: Results from sequence analysis of the coding sequences of type III collagen from 55 unrelated patients. Neurology 43:2652-2658, 1993.
33. Leblanc R, Lozano AM, van der Rest M: Collagen deficiency in cerebral aneurysms. Stroke 20:561, 1989.
34. Leblanc R, Lozano AM, van der Rest M, Guttmann RD: Absence of collagen deficiency in familial cerebral aneurysms. J Neurosurg 70:837-840, 1989.
35. Liakka A, Apaja-Sarkkinen M, Karttunen T, Autio-Harmainen H: Distribution of laminin and types IV and III collagen in fetal, infant and adult human spleens. Cell Tissue Res 263:245-252, 1991.
36. Majamaa K, Savolainen ER, Myllyla W: Synthesis of structurally unstable type III procollagen in patients with cerebral artery aneurysm. Biochim Biophys Acta 1138:191-196, 1992.
37. Navaratnam V: Organisation and reorganisation of blood vessels in embryonic development. Eye 5(Pt 2):147-150, 1991.
38. Nawashiro H: Aneurysmal walls in unruptured intracranial aneurysms. Lancet 355:1368, 2000.
39. Neil-Dwyer G, Bartlett JR, Nicholls AC, Narcisi P, Pope FM: Collagen deficiency and ruptured cerebral aneurysms: A clinical and biochemical study. J Neurosurg 59:16-20, 1983.
40. Ostergaard JR: Risk factors in intracranial saccular aneurysms: Aspects on the formation and rupture of aneurysms, and development of cerebral vasospasm. Acta Neurol Scand 80:81-98, 1989.
41. Ostergaard JR, Oxlund H: Collagen type III deficiency in patients with rupture of intracranial saccular aneurysms. J Neurosurg 67:690-696, 1987.
42. Pepper MS: Positive and negative regulation of angiogenesis: From cell biology to the clinic. Vasc Med 1:259-266, 1996.
43. Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K: Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J Cell Physiol 177:439-452, 1998.
44. Peters DG, Kassam AB, Feingold E, Heidrich-O'Hare E, Yonas H, Ferrell RE, Brufsky A: Molecular anatomy of an intracranial aneurysm: Coordinated expression of genes involved in wound healing and tissue remodeling. Stroke 32:1036-1042, 2001.
45. Pope FM, Limburg M, Schievink WI: Familial cerebral aneurysms and type III collagen deficiency. J Neurosurg 72:156-158, 1990.
46. Pope FM, Nicholls AC, Narcisi P, Bartlett J, Neil-Dwyer G, Doshi B: Some patients with cerebral aneurysms are deficient in type III collagen. Lancet 1:973-975, 1981.
47. Qureshi AI, Suarez JI, Parekh PD, Sung G, Geocadin R, Bhardwaj A, Tamargo RJ, Ulatowski JA: Risk factors for multiple intracranial aneurysms. Neurosurgery 43:22-27, 1998.
48. Ramirez F, Gayraud B, Pereira L: Marfan syndrome: New clues to genotype-phenotype correlations. Ann Med 31:202-207, 1999.
49. Ray JM, Stetler-Stevenson WG: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7:2062-2072, 1994.
50. Rice BJ, Peerless SJ, Drake CG: Surgical treatment of unruptured aneurysms of the posterior circulation. J Neurosurg 73:165-173, 1990.
51. Risau W, Lemmon V: Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 125:441-450, 1988.
52. Risau W, Sariola H, Zerwes HG, Sasse J, Ekblom P, Kemler R, Doetschman T: Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102:471-478, 1988.
53. Rutka JT, Apodaca G, Stern R, Rosenblum M: The extracellular matrix of the central and peripheral nervous systems: Structure and function. J Neurosurg 69:155-170, 1988.
54. Rutka JT, Taylor M, Mainprize T, Langlois A, Ivanchuk S, Mondal S, Dirks P: Molecular biology and neurosurgery in the third millennium. Neurosurgery 46:1034-1051, 2000.
55. Sarti C, Tuomilehto J, Salomaa V, Sivenius J, Kaarsalo E, Narva EV, Salmi K, Torppa J: Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 22:848-853, 1991.
56. Schmitt FC, Soares R: TGF-α and angiogenesis. Am J Surg Pathol 23:358-359, 1999.
57. Skirgaudas M, Awad IA, Kim J, Rothbart D, Criscuolo G: Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery 39:537-545, 1996.
58. Steiger HJ, Aaslid R, Keller S, Reulen HJ: Strength, elasticity and viscoelastic properties of cerebral aneurysms. Heart Vessels 5:41-46, 1989.
59. ter Berg HW, Dippel DW, Limburg M, Schievink WI, van Gijn J: Familial intracranial aneurysms: A review. Stroke 23:1024-1030, 1992.
60. Unemori EN, Lewis M, Constant J, Arnold G, Grove BH, Normand J, Deshpande U, Salles A, Pickford LB, Erikson ME, Hunt TK, Huang X: Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Repair Regen 8:361-370, 2000.
61. Viñuela F, Murayama Y: Experimental aneurysms. J Neurosurg 86:914-916, 1997.
62. Weir B: Unruptured intracranial aneurysms: A review. J Neurosurg 96:3-42, 2002.
63. Winn HR, Jane JA Sr, Taylor J, Kaiser D, Britz GW: Prevalence of asymptomatic incidental aneurysms: Review of 4568 arteriograms. J Neurosurg 96:43-49, 2002.
64. Yoneyama T, Kasuya H, Onda H, Akagawa H, Hashiguchi K, Nakajima T, Hori T, Inoue I: Collagen type I α2 (COL1A2) is the susceptible gene for intracranial aneurysms. Stroke 35:443-448, 2004.